BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37060504)

  • 21. [A Case of Surgical Resection of Anaplastic Carcinoma of the Pancreas(Pleomorphic Cell Type)with Poor Response to Neoadjuvant Chemotherapy].
    Naruse K; Maruyama T; Aono T; Okada T; Suzuki S; Kaneko K; Sato T; Muto I; Hasegawa M; Ichikawa H; Takizawa K; Nakano M; Shimada Y; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1601-1603. PubMed ID: 35046269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resected acinar cell carcinoma of the pancreas with tumor thrombus extending into the main portal vein: report of a case.
    Ueda T; Ku Y; Kanamaru T; Hasegawa Y; Kuroda Y; Saitoh Y
    Surg Today; 1996; 26(5):357-60. PubMed ID: 8726623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
    Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
    J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acinous-cell carcinoma of a metastatic pancreas treated by chemotherapy].
    Corbinais S; Egreteau J; Garin L; Derrien G; Boucher E; Raoul JL
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1180-1. PubMed ID: 12520210
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conversion Surgery for Pancreatic Head Cancer with Peritoneal Dissemination Following Chemotherapy for Two Years - A Case Report].
    Hatsuzawa Y; Mizuma M; Motoi F; Hata T; Iseki M; Takadate T; Ohtsuka H; Sakata N; Morikawa T; Nakagawa K; Hayashi H; Naitoh T; Kanno A; Shimosegawa T; Unno M
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):347-349. PubMed ID: 29483443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acinar cell carcinoma arising from an ectopic pancreas.
    Mizuno Y; Sumi Y; Nachi S; Ito Y; Marui T; Saji S; Matsutomo H
    Surg Today; 2007; 37(8):704-7. PubMed ID: 17643220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report.
    Ohno A; Sato Y; Nakamura E; Noguchi H; Tokumitsu T; Hiyoshi M; Nanashima A; Asada Y
    Diagn Cytopathol; 2017 Mar; 45(3):247-251. PubMed ID: 27860444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A Case of Successful Treatment with Gemcitabine plus Nab-Paclitaxel Therapy for Nonresected Pancreatic Body Cancer(Stage IVb)].
    Kaneko J; Kamiya A; Kobayashi K; Takatsuno Y; Kondoh I; Maejima K; Isogai J; Hasegawa K; Endo T; Maejima S
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):563-565. PubMed ID: 29650939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reconstruction of Portal Vein and Superior Mesenteric Vein Using Superficial Femoral Vein Graft in Surgical Resection of Pancreatic Head Cancer-A Case Report].
    Umino Y; Mizuma M; Akamatsu D; Aoki S; Iseki M; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Kume K; Masamune A; Unno M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1783-1785. PubMed ID: 35046329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
    Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
    Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curative remnant total pancreatectomy for recurrent pancreatic acinar cell carcinoma: A case report.
    Hiyoshi M; Kai K; Hamada T; Yano K; Imamura N; Nanashima A
    Int J Surg Case Rep; 2022 May; 94():107091. PubMed ID: 35462149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neoadjuvant FOLFIRINOX for Unresectable Adenocarcinoma of the Pancreas - A Case Report].
    Ochiai T; Inoue H; Nakatsuji H; Watanabe N; Yoshiyama A; Ito H; Toma A; Nakamura K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1349-1351. PubMed ID: 29394630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Case of Unresectable Pancreas Cancer with 32 Months Survival after Chemotherapy].
    Amagasa H; Fukuda A; Yamada A; Kakuta R; Kajiyama D; Kawaguchi M; Shibuya G; Maeda S; Motoyama K; Ganno H; Imai K; Ami K; Iida S; Andou M
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2417-2419. PubMed ID: 30692483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01).
    Yamaguchi J; Yokoyama Y; Fujii T; Yamada S; Takami H; Kawashima H; Ohno E; Ishikawa T; Maeda O; Ogawa H; Kodera Y; Nagino M; Ebata T
    Ann Surg; 2022 Jun; 275(6):1043-1049. PubMed ID: 35258510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer.
    Gharaibeh M; McBride A; Bootman JL; Patel H; Abraham I
    J Med Econ; 2017 Apr; 20(4):345-352. PubMed ID: 27919186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
    Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
    Perri G; Prakash L; Qiao W; Varadhachary GR; Wolff R; Fogelman D; Overman M; Pant S; Javle M; Koay EJ; Herman J; Kim M; Ikoma N; Tzeng CW; Lee JE; Katz MHG
    JAMA Surg; 2020 Sep; 155(9):832-839. PubMed ID: 32667641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma.
    Dhir M; Zenati MS; Hamad A; Singhi AD; Bahary N; Hogg ME; Zeh HJ; Zureikat AH
    Ann Surg Oncol; 2018 Jul; 25(7):1896-1903. PubMed ID: 29761331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of AFP producing pancreatic acinar cell carcinoma diagnosed by EUS FNA and treated by intraarterial injection chemotherapy].
    Mori S; Kondoh S; Ryozawa S; Urayama N; Satake M; Kitoh H; Yamashita H; Nakashima T; Gondo T; Okita K
    Nihon Shokakibyo Gakkai Zasshi; 2004 Feb; 101(2):177-82. PubMed ID: 15011443
    [No Abstract]   [Full Text] [Related]  

  • 40. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
    Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G
    BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.